
Cancer survival in the UK is falling behind other high-income nations, despite seeing an overall improvement in survival rates, according …

One of the world’s leading pharma companies in oncology is considering whether to continue investing in clinical trials in the …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

